New Radiation Treatment Significantly Increases Survival Rate
|
By MedImaging International staff writers Posted on 23 Oct 2012 |
|
A new drug treatment that mimics a naturally occurring compound found in blueberries and coffee has been developed to treat radiation exposure.
Charles R. Yates, PharmD., PhD, and colleagues Duane Miller, PhD, and Waleed Gaber, PhD, from Baylor College of Medicine (Houston, TX, USA) and the University of Tennessee Health Science Center (Memphis, USA), revealed that by using this drug, starting 24 hours after radiation exposure, increases survival in animal models by three-fold compared to placebo.
The research was presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) annual meeting and exposition, held October 2012 in Chicago, IL, USA. “Development of drugs for individuals who are exposed to high-dose radiation in a public health emergency has been a priority since the 9/11 terrorist attacks,” said Dr. Yates. “The ultimate goal is wide dissemination of non-invasive treatments after 24 hours of a mass casualty.”
The increased chances of vomiting after radiation exposure is problematic for oral treatments, the most typical noninvasive delivery approach. Injectable agents are frequently proposed as the next line of therapy, which comes with its own difficulties. Training for instance, is frequently required for injections. To fight this problem, Dr. Yates and his team designed a new delivery system that can be applied directly to the skin, similar to an adhesive bandage.
“We are extremely proud to have exclusive rights to this exciting technology,” said W. Shannon McCool, DPh, president and CEO of RxBio, the entity that has licensed the technology from the University of Tennessee Research Foundation.
This drug is also highly effective in models where radiation exposure is combined with skin wounds--a likely scenario in which people are exposed to shrapnel from dirty bombs or from associated burn wounds.
Related Links:
Baylor College of Medicine
University of Tennessee Health Science Center
Charles R. Yates, PharmD., PhD, and colleagues Duane Miller, PhD, and Waleed Gaber, PhD, from Baylor College of Medicine (Houston, TX, USA) and the University of Tennessee Health Science Center (Memphis, USA), revealed that by using this drug, starting 24 hours after radiation exposure, increases survival in animal models by three-fold compared to placebo.
The research was presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) annual meeting and exposition, held October 2012 in Chicago, IL, USA. “Development of drugs for individuals who are exposed to high-dose radiation in a public health emergency has been a priority since the 9/11 terrorist attacks,” said Dr. Yates. “The ultimate goal is wide dissemination of non-invasive treatments after 24 hours of a mass casualty.”
The increased chances of vomiting after radiation exposure is problematic for oral treatments, the most typical noninvasive delivery approach. Injectable agents are frequently proposed as the next line of therapy, which comes with its own difficulties. Training for instance, is frequently required for injections. To fight this problem, Dr. Yates and his team designed a new delivery system that can be applied directly to the skin, similar to an adhesive bandage.
“We are extremely proud to have exclusive rights to this exciting technology,” said W. Shannon McCool, DPh, president and CEO of RxBio, the entity that has licensed the technology from the University of Tennessee Research Foundation.
This drug is also highly effective in models where radiation exposure is combined with skin wounds--a likely scenario in which people are exposed to shrapnel from dirty bombs or from associated burn wounds.
Related Links:
Baylor College of Medicine
University of Tennessee Health Science Center
Diagnostic Ultrasound System
DC-80A
Half Apron
Demi
Ultrasonic Pocket Doppler
SD1
Multi-Use Ultrasound Table
Clinton
Latest Radiography News
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
- New AI Tool Helps Doctors Read Chest X‑Rays Better
- Wearable X-Ray Imaging Detecting Fabric to Provide On-The-Go Diagnostic Scanning
- AI Helps Radiologists Spot More Lesions in Mammograms
- AI Detects Fatty Liver Disease from Chest X-Rays
- AI Detects Hidden Heart Disease in Existing CT Chest Scans
- Ultra-Lightweight AI Model Runs Without GPU to Break Barriers in Lung Cancer Diagnosis
- AI Radiology Tool Identifies Life-Threatening Conditions in Milliseconds
- Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans
- AI Improves Early Detection of Interval Breast Cancers
Channels
MRI
view channel
Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
Vascular dysfunction in the spinal cord contributes to multiple neurological conditions, including traumatic injuries and degenerative cervical myelopathy, where reduced blood flow can lead to progressive... Read more
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
Ultrasound
view channel
Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
Chronic conditions such as hypertension and heart failure require close monitoring, yet today’s ultrasound imaging is largely confined to hospitals and short, episodic scans. This reactive model limits... Read more
Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Producing clear 3D images of deep blood vessels has long been difficult without relying on contrast agents, CT scans, or MRI. Standard ultrasound typically provides only 2D cross-sections, limiting clinicians’... Read more
Nuclear Medicine
view channel
PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure.... Read more
Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
Aggressive cancers such as osteosarcoma and glioblastoma often resist standard therapies, thrive in hostile tumor environments, and recur despite surgery, radiation, or chemotherapy. These tumors also... Read more
New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more
General/Advanced Imaging
view channel
3D Scanning Approach Enables Ultra-Precise Brain Surgery
Precise navigation is critical in neurosurgery, yet even small alignment errors can affect outcomes when operating deep within the brain. A new 3D surface-scanning approach now provides a radiation-free... Read more
AI Tool Improves Medical Imaging Process by 90%
Accurately labeling different regions within medical scans, a process known as medical image segmentation, is critical for diagnosis, surgery planning, and research. Traditionally, this has been a manual... Read more
New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
In pancreatic cancer, detecting whether the disease has spread to other organs is critical for determining whether surgery is appropriate. If metastasis is present, surgery is not recommended, yet current... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more